Ritzenthaler J, Roman J
Pulmonary & Critical Care Division, Department of Medicine, Atlanta Veterans Affairs Medical Center and Emory University School of Medicine, Atlanta, GA, USA.
Immunology. 1998 Oct;95(2):264-71. doi: 10.1046/j.1365-2567.1998.00597.x.
Human monocytic cells express interleukin-1beta (IL-1beta) when stimulated with the extracellular matrix glycoprotein, fibronectin (FN). Protein kinase C (PKC) activation is considered important for this process; however, the metabolic steps at which PKC acts upon to mediate the FN-induced IL-1beta response remain unclear. We performed an analysis of the mechanisms by which two PKC inhibitors, Calphostin C and Staurosporine, prevent the FN-induced IL-1beta response. Both inhibitors blocked the secretion of IL-1beta protein into the media of peripheral blood mononuclear cells exposed to FN. Immunoprecipitation analysis revealed that under these circumstances, Calphostin C inhibited the production of IL-1beta protein, whereas Staurosporine allowed protein production, but inhibited its secretion. To determine the mechanisms responsible for these differences, we turned to human U937 promonocytic cells. U937 cells transfected with the human full-length IL-1beta promoter connected to a luciferase reporter gene were submitted to transcription assays, Northern blotting, and DNA electrophoresis mobility gel shift assays. These studies revealed that Calphostin C inhibited the nuclear translocation of the transcription factor activator protein-1 (AP-1) which is considered necessary for FN induction of IL-1beta gene transcription, and prevented the transcription of the IL-1beta gene. In contrast, Staurosporine alone induced AP-1 translocation and stimulation of the gene. Overall, our data indicate that Calphostin C prevents the transcription of the IL-1beta gene thereby inhibiting protein synthesis. Based on the high specificity of this compound for PKC, we conclude that PKC is necessary for FN-induced IL-1beta protein production. In contrast, Staurosporine prevented secretion of IL-1beta by unknown mechanisms.
人单核细胞在受到细胞外基质糖蛋白纤连蛋白(FN)刺激时会表达白细胞介素-1β(IL-1β)。蛋白激酶C(PKC)激活被认为对这一过程很重要;然而,PKC作用于介导FN诱导的IL-1β反应的代谢步骤仍不清楚。我们分析了两种PKC抑制剂,钙泊三醇C和星形孢菌素,阻止FN诱导的IL-1β反应的机制。两种抑制剂都阻断了IL-1β蛋白分泌到暴露于FN的外周血单核细胞培养基中。免疫沉淀分析表明,在这些情况下,钙泊三醇C抑制IL-1β蛋白的产生,而星形孢菌素允许蛋白产生,但抑制其分泌。为了确定造成这些差异的机制,我们转向人U937原单核细胞。用连接有荧光素酶报告基因的人全长IL-1β启动子转染的U937细胞进行转录测定、Northern印迹和DNA电泳迁移率凝胶迁移试验。这些研究表明,钙泊三醇C抑制转录因子激活蛋白-1(AP-1)的核转位(这被认为是FN诱导IL-1β基因转录所必需的),并阻止IL-1β基因的转录。相反,单独使用星形孢菌素会诱导AP-1转位并刺激该基因。总体而言,我们的数据表明,钙泊三醇C阻止IL-1β基因的转录,从而抑制蛋白质合成。基于该化合物对PKC的高特异性,我们得出结论,PKC是FN诱导的IL-1β蛋白产生所必需的。相反,星形孢菌素通过未知机制阻止IL-1β的分泌。